publication venue for
- Sex-specific association of cardiovascular drug doses with adverse outcomes in atrial fibrillation. 11:e002720-e002720. 2024
- Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort. 11:e002567-e002567. 2024
- Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke. 10:e002506-e002506. 2023
- Associations of health-related quality of life with major adverse cardiovascular and cerebrovascular events for individuals with ischaemic heart disease: systematic review, meta-analysis and evidence mapping. 10:e002452-e002452. 2023
- Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry. 10:e002275-e002275. 2023
- Sex differences of vascular brain lesions in patients with atrial fibrillation. 9:e002033-e002033. 2022
- Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF. 9:e002038-e002038. 2022
- Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe. 8:e001681-e001681. 2021
- Heavy alcohol drinking and subclinical echocardiographic abnormalities of structure and function. 8:e001457-e001457. 2021
- Heart rate and adverse outcomes in patients with prevalent atrial fibrillation. 8:e001606-e001606. 2021
- Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas. 8:e001471-e001471. 2021
- High-dose versus low-dose angiotensin converting enzyme inhibitors in heart failure: systematic review and meta-analysis. 7:e001228-e001228. 2020
- Modifiable risk factors predict incident atrial fibrillation and heart failure. 7:e001092-e001092. 2020
- Bariatric surgery among patients with heart failure: a systematic review and meta-analysis. 5:e000910-e000910. 2018
- High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme. 3:e000515-e000515. 2016
- Health system barriers and facilitators to medication adherence for the secondary prevention of cardiovascular disease: a systematic review. 3:e000438-e000438. 2016
- Interpreting angina: symptoms along a gender continuum. 3:e000376-e000376. 2016
- Adherence to process of care quality indicators after percutaneous coronary intervention in Ontario, Canada: a retrospective observational cohort study. 2:e000200-e000200. 2015